What is the difference between hemodialysis and renal replacement therapy (RRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hemodialysis vs. Renal Replacement Therapy: Understanding the Terminology

Renal replacement therapy (RRT) is the umbrella term that encompasses all modalities used to replace kidney function, while hemodialysis is one specific type of RRT. 1

Key Conceptual Framework

RRT includes multiple treatment modalities:

  • Hemodialysis (intermittent or continuous)
  • Peritoneal dialysis
  • Hemofiltration
  • Hemodiafiltration
  • Kidney transplantation

1, 2, 3, 4

Think of it this way: RRT is the category, hemodialysis is one option within that category—much like "transportation" encompasses cars, trains, and planes, where a car is just one specific mode.

Clinical Context Matters

The terminology distinction becomes particularly important in acute settings versus chronic kidney disease:

In Acute Kidney Injury (ICU patients):

RRT modalities are selected based on hemodynamic stability 1:

  • Continuous RRT (CRRT): Preferred for hemodynamically unstable patients, though RCTs haven't demonstrated mortality benefit over intermittent hemodialysis
  • Intermittent hemodialysis (IHD): Appropriate for stable patients; more practical and cost-effective
  • Hybrid therapies (SLED/PIRRT): Combine benefits of both approaches

In Chronic Kidney Disease:

When RRT becomes permanent, specify the exact modality 1:

  • Transplant
  • Hemodialysis (typically intermittent, 3x/week for 3-4 hours)
  • Peritoneal dialysis

Important Communication Guideline

KDIGO 2020 guidelines emphasize patient-centered language 1: When speaking with patients and families, avoid the term "RRT" entirely. Use plain language like "life support" or "kidney machine" instead. Only specify the exact type (hemodialysis, peritoneal dialysis, transplant) once treatment becomes permanent and the patient enters chronic dialysis pathways.

Common Pitfall to Avoid

Don't use "hemodialysis" and "RRT" interchangeably in clinical documentation or discussions. RRT modality selection should be based on 1:

  • Patient hemodynamic status
  • Available resources and personnel expertise
  • Clinical goals (fluid removal, solute clearance, acid-base balance)
  • Patient characteristics and preferences

The choice of RRT modality does not appear to impact kidney function recovery, so selection should prioritize immediate clinical needs rather than long-term renal outcomes 1.

Related Questions

What are the different modalities of renal replacement therapy, including in‑center intermittent hemodialysis, home hemodialysis, peritoneal dialysis (CAPD and APD), continuous renal replacement therapies (CRRT) such as CVVH, CVVHD, CVVHDF, and kidney transplantation?
What is PIRRT (Prolonged Intermittent Renal Replacement Therapy) dialysis?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
How is chest pain of cardiac origin classified in adult patients?
Is mismatch repair (MMR) deficiency more favorable than MMR proficiency in endometrial cancer?
What is the recommended dosing and dose adjustment of finerenone based on eGFR and serum potassium levels?
When should radiation therapy be initiated for a patient with a portal vein tumor thrombus (vp4) after a subcapsular hepatic bleed, assuming the bleed is stable, liver function is Child‑Pugh A or B, and the patient is receiving systemic therapy with atezolizumab (1200 mg IV every 3 weeks) and lenvatinib (12 mg orally daily, or 8 mg if body weight < 60 kg)?
Is finerenone useful in hypertrophic cardiomyopathy (HCM)?
What is the recommended diagnostic work‑up for malaria in a patient presenting with fever, chills, headache, myalgia, or sweats who has recently traveled to or resides in a malaria‑endemic region?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.